Her er nyere publikasjoner med bidrag fra K2 basert på siste ukes litteratursøk på PubMed (og eventuelt artikler som ikke har vært med i tidligere lister). Denne gangen inkluderer listen totalt 11 nyere publikasjoner. Oppføringene forekommer i den rekkefølgen de er mottatt fra NCBI. Hvis du har publikasjoner som ikke er inkludert i denne eller tidligere lister, sendes referansene til Oda Barth Vedøy.

1. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice.

Tollånes MC, Sjaastad GE, Aarli BB, Sandberg S.Tollånes MC, et al.BMC Fam Pract. 2020 Nov 18;21(1):235. doi: 10.1186/s12875-020-01310-x.BMC Fam Pract. 2020. PMID: 33208085

 

2. Iodine Status and Thyroid Function in a Group of Seaweed Consumers in Norway.

Aakre I, Tveito Evensen L, Kjellevold M, Dahl L, Henjum S, Alexander J, Madsen L, Markhus MW.Aakre I, et al.Nutrients. 2020 Nov 13;12(11):E3483. doi: 10.3390/nu12113483.Nutrients. 2020. PMID: 33202773

 

3. Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer.

Fasmer KE, Hodneland E, Dybvik JA, Wagner-Larsen K, Trovik J, Salvesen Ø, Krakstad C, Haldorsen IHS.Fasmer KE, et al.J Magn Reson Imaging. 2020 Nov 16. doi: 10.1002/jmri.27444. Online ahead of print.J Magn Reson Imaging. 2020. PMID: 33200420

 

4. Cryptosporidium Infections in Africa-How Important Is Zoonotic Transmission? A Review of the Evidence.

Robertson LJ, Johansen ØH, Kifleyohannes T, Efunshile AM, Terefe G.Robertson LJ, et al.Front Vet Sci. 2020 Oct 8;7:575881. doi: 10.3389/fvets.2020.575881. eCollection 2020.Front Vet Sci. 2020. PMID: 33195574

 

5. Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms.

Keindl M, Fedotkina O, du Plessis E, Jain R, Bergum B, Mygind Jensen T, Laustrup Møller C, Falhammar H, Nyström T, Catrina SB, Jörneskog G, Groop L, Eliasson M, Eliasson B, Brismar K, Nilsson PM, Berg TJ, Appel S, Lyssenko V.Keindl M, et al.Front Endocrinol (Lausanne). 2020 Oct 30;11:575469. doi: 10.3389/fendo.2020.575469. eCollection 2020.Front Endocrinol (Lausanne). 2020. PMID: 33193091

 

6. Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial.

Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H; OMEMI investigators.Kalstad AA, et al.Circulation. 2020 Nov 15. doi: 10.1161/CIRCULATIONAHA.120.052209. Online ahead of print.Circulation. 2020. PMID: 33191772

 

7. Interferons and innate immune activation in autoimmune congenital heart block.

Ambrosi A, Thorlacius GE, Sonesson SE, Wahren-Herlenius M.Ambrosi A, et al.Scand J Immunol. 2020 Nov 14:e12995. doi: 10.1111/sji.12995. Online ahead of print.Scand J Immunol. 2020. PMID: 33188653

 

8. The core clock transcription factor BMAL1 drives circadian β-cell proliferation during compensatory regeneration of the endocrine pancreas.

Petrenko V, Stolovich-Rain M, Vandereycken B, Giovannoni L, Storch KF, Dor Y, Chera S, Dibner C.Petrenko V, et al.Genes Dev. 2020 Nov 12. doi: 10.1101/gad.343137.120. Online ahead of print.Genes Dev. 2020. PMID: 33184223

 

9. Efficient and crucial quality control of HAP1 cell ploidy status.

Beigl TB, Kjosås I, Seljeseth E, Glomnes N, Aksnes H.Beigl TB, et al.Biol Open. 2020 Nov 12;9(11):bio057174. doi: 10.1242/bio.057174.Biol Open. 2020. PMID: 33184093

 

10. Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.

Carreño JM, McDonald JU, Hurst T, Rigsby P, Atkinson E, Charles L, Nachbagauer R, Behzadi MA, Strohmeier S, Coughlan L, Aydillo T, Brandenburg B, García-Sastre A, Kaszas K, Levine MZ, Manenti A, McDermott AB, Montomoli E, Muchene L, Narpala SR, Perera RAPM, Salisch NC, Valkenburg SA, Zhou F, Engelhardt OG, Krammer F.Carreño JM, et al.Vaccines (Basel). 2020 Nov 9;8(4):E666. doi: 10.3390/vaccines8040666.Vaccines (Basel). 2020. PMID: 33182279

 

11. Hyperferritinemi-katarakt-syndrom.

Benneche A, Sandnes M, Bakke Å, Reikvam H. Tidsskr Nor Laegeforen. 2020 Nov 9;140(16). doi: 10.4045/tidsskr.20.0255. Print 2020 Nov 10.PMID: 33172243